Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ibernator-specific blood complex, 20 kDa subunit pseudogene (ENSG00000233632) is classified as a pseudogene, meaning it is a non-functional segment of genomic DNA that resembles a gene but is generally incapable of producing a functional protein product. While some pseudogenes are transcribed and may play regulatory roles via non-coding RNAs, there is no evidence that this specific pseudogene is associated with any biological function, disease process, or therapeutic druggability. It is not considered a receptor, enzyme, or classic drug target. The classification "pseudogene" is based on the absence of protein-coding capacity, though recent research suggests some pseudogenes may act in regulatory networks; there is no published information to indicate this role for ENSG00000233632 specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ibernator-specific blood complex, 20 kDa subunit pseudogene.